Search

Catherine R Auge

from Damascus, MD
Age ~51

Catherine Auge Phones & Addresses

  • 10755 Middleboro Dr, Damascus, MD 20872
  • Gaithersburg, MD
  • Germantown, MD
  • Austin, TX
  • 11260 Chatterly Loop, Manassas, VA 20109 (703) 330-1670
  • Sleepy Hollow, NY
  • Haymarket, VA
  • Woodland Hills, CA
  • Arcadia, CA
  • Azusa, CA
  • 9890 Wshingtonian Blvd Apt 510, Gaithersburg, MD 20878 (703) 753-9998

Education

Degree: High school graduate or higher

Business Records

Name / Title
Company / Classification
Phones & Addresses
Catherine Auge
Manager
AMERICAN TYPE CULTURE COLLECTION
Nonclassifiable Establishments · Noncommercial Research Organization
10801 University Blvd, Manassas, VA 20110
PO Box 1549, Manassas, VA 20108
(703) 365-2700, (703) 397-7188

Publications

Us Patents

Compositions And Methods For Diagnosis And Treatment For Type 2 Diabetes

View page
US Patent:
20080300170, Dec 4, 2008
Filed:
Sep 18, 2007
Appl. No.:
11/901925
Inventors:
Cohava Gelber - Nokesville VA, US
Liping Liu - Manassas VA, US
Zhidong Xie - Manassas VA, US
Pranvera Ikonomi - Manassas VA, US
John R. Simms - Haymarket VA, US
Catherine R. Auge - Haymarket VA, US
International Classification:
A61K 38/28
G01N 33/53
C07K 16/18
A61P 3/10
C12Q 1/68
US Classification:
514 3, 435 71, 435 6, 5303879
Abstract:
The present invention relates generally to the identification of biological markers associated with an increased risk of developing Diabetes, as well as methods of using such biological markers in diagnosis and prognosis of Diabetes. The biological markers of the invention may indicate new targets for therapy or constitute new therapeutics for the treatment or prevention of Diabetes.

Compositions And Methods For Diagnosis And Treatment Of Type 2 Diabetes

View page
US Patent:
20090203602, Aug 13, 2009
Filed:
Jan 12, 2009
Appl. No.:
12/319883
Inventors:
Cohava Gelber - Nokesville VA, US
Liping Liu - Manassas VA, US
Zhidong Xie - Manassas VA, US
Pranvera Ikonomi - Manassas VA, US
John R. Simms - Haymarket VA, US
Catherine R. Auge - Haymarket VA, US
International Classification:
A61K 38/17
C07K 14/47
C12N 15/12
C12N 9/99
A61P 3/10
US Classification:
514 12, 530324, 536 235, 435184, 530350
Abstract:
The present invention relates generally to the identification of biological markers associated with an increased risk of developing Diabetes, as well as methods of using such biological markers in diagnosis and prognosis of Diabetes. The biological markers of the invention may indicate new targets for therapy or constitute new therapeutics for the treatment or prevention of Diabetes.

Compositions And Methods For Diagnosis And Treatment Of Type 2 Diabetes

View page
US Patent:
20100197596, Aug 5, 2010
Filed:
Apr 13, 2010
Appl. No.:
12/759072
Inventors:
Cohava Gelber - Nokesville VA, US
Liping Liu - Manassas VA, US
Zhidong Xie - Manassas VA, US
Pranvera Ikonomi - Manassas VA, US
John R. Simms - Haymarket VA, US
Catherine R. Auge - Haymarket VA, US
Assignee:
AMERICAN TYPE CULTURE COLLECTION (ATCC®) - Manassas VA
International Classification:
A61K 38/16
A61P 3/10
US Classification:
514 12
Abstract:
The present invention relates generally to the identification of biological markers associated with an increased risk of developing Diabetes, as well as methods of using such biological markers in diagnosis and prognosis of Diabetes. The biological markers of the invention may indicate new targets for therapy or constitute new therapeutics for the treatment or prevention of Diabetes.

Compositions And Methods For Diagnosis And Treatment Of Type 2 Diabetes

View page
US Patent:
20100267052, Oct 21, 2010
Filed:
May 10, 2010
Appl. No.:
12/776601
Inventors:
Cohava Gelber - Nokesville VA, US
Liping Liu - Manassas VA, US
Zhidong Xie - Manassas VA, US
Pranvera Ikonomi - Manassas VA, US
John R. Simms - Haymarket VA, US
Catherine R. Auge - Haymarket VA, US
Assignee:
AMERICAN TYPE CULTURE COLLECTION - Manassas VA
International Classification:
G01N 33/53
G01N 33/566
US Classification:
435 71, 436501
Abstract:
The present invention relates generally to the identification of biological markers associated with an increased risk of developing Diabetes, as well as methods of using such biological markers in diagnosis and prognosis of Diabetes. The biological markers of the invention may indicate new targets for therapy or constitute new therapeutics for the treatment or prevention of Diabetes.
Catherine R Auge from Damascus, MD, age ~51 Get Report